|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
 Back to Reuters Health News Archives
Reuters Health News: 12-18-2004
TOKYO (Reuters) - Five people in Japan may have been infected with the bird flu virus after an outbreak among chickens in February, but there is no risk they will develop symptoms and no chance of more infections, the government said on Saturday.
WASHINGTON (Reuters) - U.S. officials who just weeks ago worried that the nation's flu shot supply would run short said on Friday they are expanding the group of people who should get the vaccine so that doses do not go to waste.
NEW YORK (Reuters) - Pfizer Inc. on Friday said its popular Celebrex arthritis drug more than doubled the risk of heart attack in a large cancer-prevention trial, a setback that comes just weeks after Merck & Co. recalled its similar Vioxx drug due to heart safety risks.
CHICAGO (Reuters) - Doctors writing in a prominent medical journal on Friday recommended that physicians stop prescribing Pfizer Inc.'s Bextra painkiller, just as a large study found the drug maker's sister drug, Celebrex, doubled risk of heart attacks.
NEW YORK (Reuters Health) - Results of a new study provide more evidence that being depressed increases the likelihood of developing diabetes.
NEW YORK (Reuters Health) - Over-the-counter (OTC) benzoyl peroxide cream clears up acne as well as prescription antibiotics -- and at a fraction of the cost, according to new study findings released Friday.
NEW YORK (Reuters Health) - Screening for cancer quite often produces a false-positive result, and this can lead to costly -- and ultimately unnecessary -- follow-up testing, according to a new report.
NEW YORK (Reuters Health) - About 60 percent of Americans aged 50 or older who are at average risk for colorectal cancer -- some 42 million people -- have not yet been screened, researchers report.
LONDON (Reuters) - AstraZeneca Plc suffered its third setback in two months on Friday as lung cancer drug Iressa failed to help patients live longer in a major clinical trial, sending its shares down more than 8 percent.
SINGAPORE (Reuters) - Singapore is to fine people who allow mosquitoes to breed in their homes in a bid to curb dengue fever, a sometimes fatal disease that has soared to a 10-year high in the island-state.
|
|
